Clinical Trial Update: Fluvastatin After Heart Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating fluvastatin in patients after heart transplantation for hypercholesterolemia; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Fluvastatin (fluvastatin)

Snippet

Sponsor: University of Bologna | Conditions: Heart Transplantation, Hypercholesterolemia | Phase 4 | Status: UNKNOWN